Abiopharma

🔍 Eckert Kurt M. (Director)

Company: MIAMI INTERNATIONAL HOLDINGS, INC. (MIAX)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 2,267 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 144,642.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 4,970 shares of Common Stock (Direct)
  Date: 2026-06-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 149,612.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 7,713 shares of Nonqualified Stock Option (Right to Buy) at $40.24 per share (Derivative)
  Date: 2026-06-16 | Code: A | Expires: 2036-06-15 | equity_swap_involved: 0 | shares_owned_after: 7,713.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: The amount represents restricted stock units ("RSUs") that fully vested on the date of grant. Each RSU represents a right to receive one share of the Issuer's common stock.
• F2: The amount represents RSUs that vest on the last business day immediately preceding the 2027 annual meeting of stockholders, subject to the reporting person's continued service to the Issuer through the vesting date.
• F3: 3,856 of the shares subject to this option will vest on June 30, 2026, 1,929 of the shares subject to this option will vest on September 30, 2026 and the remaining 1,928 of the shares subject to this option will vest on December 31, 2026, subject to the Reporting Person's continued service to the Issuer or its subsidiaries through the applicable vesting date.